Stocktoria
Summit Therapeutics Inc. SMMT
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2004-10-14
Summit Therapeutics Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 7,898,585 | $61.6M | 1.02% |
| D. E. Shaw & Co., Inc. | 2,242,229 | $42.5M | 0.29% |
| CITADEL ADVISORS LLC | 1,060,943 | $20.1M | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 981,185 | $18.6M | 0.13% |
| Point72 Asset Management, L.P. | 801,086 | $15.2M | 0.1% |
| AQR CAPITAL MANAGEMENT LLC | 443,757 | $8.1M | 0.06% |
| MILLENNIUM MANAGEMENT LLC | 126,273 | $2.4M | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.